Coeurative

Manufacturing · Virginia, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

201 Mcclanahan St SW, Roanoke, Virginia,...

Phone Number

(540) 443-3911

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Coeurative

Coeurative, Inc. is focused on developing innovative treatments for Coronary Artery Disease, particularly targeting angina pectoris and patients suffering from INOCA. The company is pioneering a unique approach that utilizes a cellular response to improve blood flow more effectively than existing vasodilators. With a commitment to transforming heart disease treatment, Coeurative aims to provide both immediate relief and long-term benefits through its lead compound, CR-0305. The company addresses a significant market opportunity, with over 10 million Americans affected by angina pectoris and a projected global market exceeding $15 billion by 2029.Explore more
Popular SearchesCoeurative IncCoeurativeSIC Code 28,283NAICS Code 32,325Show more

Coeurative Org Chart

JS
United States flag for contact location.

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

Is Coeurative your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Coeurative

Compare insights from companies similar to Coeurative, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Coeurative

<$5M
1-10
Private
-
2012
JS
John SchmedtjePresident & CEO
$7.1M
11-50
Private
-
2001
DS
David SolomonMedical Director
$6.3M
11-50
Private
<$5M
2007
PB
Pamela BaxterDirector, Quality
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2016
MK
Mary KlinkDirector, Strategic Operations
<$5M
1-10
Private
-
2001
MC
Mark CameronChief Scientific Officer
<$5M
11-50
Private
-
2012
AI
Anita IlchevaChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Coeurative is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Coeurative is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Coeurative.

Coeurative Tech Stack

A closer look at the technologies used by Coeurative

Coeurative News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Coeurative

What is Coeurative's official website?
Coeurative's official website is www.coeurative.com
What is Coeurative's Revenue?
Coeurative's revenue is <$5 Million
What is Coeurative's SIC code?
Coeurative's SIC: 28,283
What is Coeurative's NAICS code?
Coeurative's NAICS: 32,325
How many employees does Coeurative have?
Coeurative has 1-10 employees
What industry does Coeurative belong to?
Coeurative is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Coeurative competition?
Coeurative top competitors include: Matrix Biomed, Velesco Pharmaceutical Services, Pipeline Drugs, Sofpromed
What technology does Coeurative use?
Some of the popular technologies that Coeurative uses are: WordPress.org, PHP, Google Font API, YouTube
How do I contact Coeurative?
Coeurative contact info: Phone number: (540) 443-3911 Website: www.coeurative.com
What does Coeurative do?

Coeurative, Inc. is focused on developing innovative treatments for Coronary Artery Disease, particularly targeting angina pectoris and patients suffering from INOCA. The company is pioneering a unique approach that utilizes a cellular response to improve blood flow more effectively than existing vasodilators. With a commitment to transforming hear... t disease treatment, Coeurative aims to provide both immediate relief and long-term benefits through its lead compound, CR-0305. The company addresses a significant market opportunity, with over 10 million Americans affected by angina pectoris and a projected global market exceeding $15 billion by 2029.Read More

Is Coeurative a public company?
Coeurative is private company therefore does not currently have an official ticker symbol
See more information about Coeurative

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.